Log In Sign up
The largest database of trusted experimental protocols

Hsp90 alpha beta

Manufactured by Santa Cruz Biotechnology
Visit Supplier

Hsp90 alpha/beta is a laboratory product that serves as a molecular chaperone, assisting in the folding and stabilization of various client proteins. It is essential for the proper functioning of numerous cellular processes.

Automatically generated - may contain errors

Lab products found in correlation

Pan akt, by Cell Signaling Technology (2 mentions) Pakt t308, by Cell Signaling Technology (2 mentions) Ps6 s235 236, by Cell Signaling Technology (2 mentions) Alexa680 coupled secondary antibodies, by Thermo Fisher Scientific (2 mentions) Odyssey infrared imaging system, by LI COR (2 mentions) Pakt s473, by Cell Signaling Technology (2 mentions) P27kip1 sc 528, by Santa Cruz Biotechnology (1 mentions) P27kip1, by Santa Cruz Biotechnology (1 mentions)

Spelling variants of this product

HSP90 (187 citations)

2 protocols using hsp90 alpha beta

1

Western Blot Analysis of AKT and S6 Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole-cell lysates were prepared and isolated proteins separated in SDS-polyacrylamide gels, transferred to polyvinylidene difluoride membranes and incubated at 4°C overnight with the following primary antibodies: pAKT-T308 (#2965, RRID:AB_2255933), pAKT-S473 (#4060, RRID:AB_2315049), pan-AKT (#4691, RRID:AB_915783), p-S6-S235/236 (#4858, RRID:AB_916156; all from Cell Signaling Technology) and p27Kip1 (sc528, RRID:AB_632129), Skp2 (sc7164, RRID:AB_2187650) and Hsp90 alpha/beta (sc13119, RRID:AB_675659; all from Santa Cruz Biotechnology). Primary antibodies were followed by Alexa680-coupled secondary antibodies (Thermo Fisher Scientific) and detected by the Odyssey Infrared Imaging System (Licor, Bad Homburg, Germany).
Falcomatà C., Bärthel S., Ulrich A., Diersch S., Veltkamp C., Rad L., Boniolo F., Solar M., Steiger K., Seidler B., Zukowska M., Madej J., Wang M., Öllinger R., Maresch R., Barenboim M., Eser S., Tschurtschenthaler M., Mehrabi A., Roessler S., Goeppert B., Kind A., Schnieke A., Robles M.S., Bradley A., Schmid R.M., Schmidt-Supprian M., Reichert M., Weichert W., Sansom O.J., Morton J.P., Rad R., Schneider G, & Saur D. (2021). Genetic Screens Identify a Context-Specific PI3K/p27Kip1 Node Driving Extrahepatic Biliary Cancer. Cancer Discovery, 11(12), 3158-3177.
+ Open protocol
+ Expand
2

Western Blot Analysis of AKT Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole-cell lysates were prepared, and isolated proteins were separated in SDS-polyacrylamide gels, transferred to polyvinylidene difluoride membranes, and incubated at 4°C overnight with the following primary antibodies: pAKT-T308 (#2965, RRID:AB_2255933), pAKT-S473 (#4060, RRID:AB_2315049), pan-AKT (#4691, RRID:AB_915783), p-S6-S235/236 (#4858, RRID:AB_916156; all from Cell Signaling Technology) and p27Kip1 (sc528, RRID:AB_632129), Skp2 (sc7164, RRID:AB_2187650), and Hsp90 alpha/beta (sc13119, RRID:AB_675659; all from Santa Cruz Biotechnology). Primary antibodies were followed by Alexa680-coupled secondary antibodies (Thermo Fisher Scientific) and detected by the Odyssey Infrared Imaging System (Licor).
Falcomatà C., Bärthel S., Ulrich A., Diersch S., Veltkamp C., Rad L., Boniolo F., Solar M., Steiger K., Seidler B., Zukowska M., Madej J., Wang M., Öllinger R., Maresch R., Barenboim M., Eser S., Tschurtschenthaler M., Mehrabi A., Roessler S., Goeppert B., Kind A., Schnieke A., Robles M.S., Bradley A., Schmid R.M., Schmidt-Supprian M., Reichert M., Weichert W., Sansom O.J., Morton J.P., Rad R., Schneider G, & Saur D. (2021). Genetic Screens Identify a Context-Specific PI3K/p27Kip1 Node Driving Extrahepatic Biliary Cancer. Cancer Discovery, 11(12), 3158-3177.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!